Teng G - Search Results

1

Incidence and risk factors for second malignancies among patients with myeloproliferative neoplasms.

Zhang Y, Han Y, Teng G, Du C, Gao S, Yuan W, Zhang L, Bai J. Zhang Y, et al. Among authors: teng g. Cancer Med. 2023 Apr;12(8):9236-9246. doi: 10.1002/cam4.5666. Epub 2023 Feb 2. Cancer Med. 2023. PMID: 36727544 Free PMC article.

2

Thrombosis among 1537 patients with JAK2^V617F -mutated myeloproliferative neoplasms: Risk factors and development of a predictive model.

Zhang Y, Zhou Y, Wang Y, Teng G, Li D, Wang Y, Du C, Chen Y, Zhang H, Li Y, Fu L, Chen K, Bai J. Zhang Y, et al. Among authors: teng g. Cancer Med. 2020 Mar;9(6):2096-2105. doi: 10.1002/cam4.2886. Epub 2020 Jan 28. Cancer Med. 2020. PMID: 31994332 Free PMC article.

3

Thrombosis in patients with post-polycythemia vera myelofibrosis: incidence and risk factors.

Teng G, Zhou Y, Zhang Y, Hu N, Liu T, Han Y, Gao C, Zhang L, Bai J. Teng G, et al. Thromb Res. 2022 Apr;212:38-43. doi: 10.1016/j.thromres.2022.02.006. Epub 2022 Feb 12. Thromb Res. 2022. PMID: 35219930

4

[Bioinformatics Analysis of Core Genes and Key Pathways in Myelodysplastic Syndrome].

Wang Y, Wang YS, Hu NB, Teng GS, Zhou Y, Bai J. Wang Y, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Jun;30(3):804-812. doi: 10.19746/j.cnki.issn.1009-2137.2022.03.023. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022. PMID: 35680809 Chinese.

5

[Clinical Value of Genetic Susceptibility Genes for Myeloid Neoplasm in Myeloproliferative Neoplasm].

Gao S, Duan YF, Zhang YH, Teng GS, DU CX, Bai J. Gao S, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Auguest;31(4):1119-1124. doi: 10.19746/j.cnki.issn.1009-2137.2023.04.029. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023. PMID: 37551486 Chinese.

6

[Clinical and laboratory features of SF3B1-mutated myeloproliferative neoplasms].

Peng L, Zhang YH, Teng GS, Du CX, Wang Y, Hu NB, Li YQ, Shao ZH, Bai J. Peng L, et al. Among authors: teng gs. Zhonghua Yi Xue Za Zhi. 2023 Nov 21;103(43):3472-3477. doi: 10.3760/cma.j.cn112137-20230928-00609. Zhonghua Yi Xue Za Zhi. 2023. PMID: 37981774 Chinese.

7

[Efficacy and safety of pegylated interferon alpha-2b for patients with myeloproliferative neoplasm].

Teng GS, Zhang YH, Wang Y, Du CX, Li YQ, Hu NB, Xiang GP, Shao ZH, Bai J. Teng GS, et al. Zhonghua Yi Xue Za Zhi. 2023 Dec 5;103(45):3645-3651. doi: 10.3760/cma.j.cn112137-20231007-00654. Zhonghua Yi Xue Za Zhi. 2023. PMID: 38018063 Chinese.

8

[Analysis of risk factors for thromboembolism in patients with JAK2^V617F gene mutation positive myeloproliferative neoplasms].

Zhang YH, Teng GS, Ma JY, Hu X, Du CX, Wang Y, Hu NB, Li YQ, Shao ZH, Bai J. Zhang YH, et al. Among authors: teng gs. Zhonghua Yi Xue Za Zhi. 2023 Dec 5;103(45):3652-3657. doi: 10.3760/cma.j.cn112137-20231007-00647. Zhonghua Yi Xue Za Zhi. 2023. PMID: 38018064 Chinese.

9

[Clinical features of hemophagocytic lymphohistiocytosis associated with myeloid neoplasms: a report of 8 cases].

Li YQ, Zhang YH, Teng GS, Hu NB, Wang Y, Duan YF, Bai J. Li YQ, et al. Among authors: teng gs. Zhonghua Xue Ye Xue Za Zhi. 2023 Nov 14;44(11):949-951. doi: 10.3760/cma.j.issn.0253-2727.2023.11.012. Zhonghua Xue Ye Xue Za Zhi. 2023. PMID: 38185527 Free PMC article. Chinese. No abstract available.

10

[Analysis of risk factors for venous thromboembolism in patients with polycythemia vera and establishment of a prediction model].

Ma JY, Zhang YH, Teng GS, Du CX, Zhang HQ, Wang Y, Li YQ, Duan YF, Zhou Y, Shao ZH, Bai J. Ma JY, et al. Among authors: teng gs. Zhonghua Yi Xue Za Zhi. 2024 Jul 2;104(25):2336-2341. doi: 10.3760/cma.j.cn112137-20240304-00476. Zhonghua Yi Xue Za Zhi. 2024. PMID: 38951106 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

754 results

Search Page

Filters